Pfizer, Inc. Stock

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:12 2024-05-03 pm EDT 5-day change 1st Jan Change
27.81 USD +0.40% Intraday chart for Pfizer, Inc. +9.49% -3.40%
Sales 2024 * 60.27B Sales 2025 * 62.55B Capitalization 157B
Net income 2024 * 7.18B Net income 2025 * 10.17B EV / Sales 2024 * 3.51 x
Net Debt 2024 * 53.77B Net Debt 2025 * 42.59B EV / Sales 2025 * 3.2 x
P/E ratio 2024 *
19.8 x
P/E ratio 2025 *
14 x
Employees 88,000
Yield 2024 *
6.09%
Yield 2025 *
6.19%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.43%
1 week+9.49%
Current month+8.55%
1 month+2.17%
3 months+3.27%
6 months-11.04%
Current year-3.40%
More quotes
1 week
25.54
Extreme 25.54
27.94
1 month
25.20
Extreme 25.2
27.94
Current year
25.20
Extreme 25.2
30.28
1 year
25.20
Extreme 25.2
40.37
3 years
25.20
Extreme 25.2
61.71
5 years
25.20
Extreme 25.2
61.71
10 years
25.20
Extreme 25.2
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-05-03 27.81 +0.40% 60,568,852
24-05-02 27.7 +1.91% 69,649,012
24-05-01 27.18 +6.09% 97,521,564
24-04-30 25.62 -0.08% 38,017,739
24-04-29 25.64 +0.94% 41,674,405

Delayed Quote Nyse, May 03, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.81 USD
Average target price
31.89 USD
Spread / Average Target
+14.68%
Consensus